KLYG (Kelyniam Global) Buyback Yield %: 0.00 (As of Aug. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Kelyniam Global Buyback Yield %?

Kelyniam Global KLYG Buyback Yield % is 0.00 as of Aug. 17, 2026.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Kelyniam Global's current buyback yield was 0.00%.

Kelyniam Global Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Kelyniam Global's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kelyniam Global Buyback Yield % Chart

Kelyniam Global Annual Data
Trend Dec06 Dec07
Buyback Yield %
0.00 0.00

Kelyniam Global Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08
Buyback Yield % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

KLYG vs VASO, WCUI, MODD: Buyback Yield % Comparison

For the Medical Devices subindustry, Kelyniam Global's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kelyniam Global Buyback Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Kelyniam Global's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Kelyniam Global's Buyback Yield % falls into.


Kelyniam Global Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Kelyniam Global's Buyback Yield for the fiscal year that ended in Dec. 2007 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (-0.001 + 0.032) / 0
=N/A%

Kelyniam Global's annualized Buyback Yield for the quarter that ended in Mar. 2008 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0.02) / 0
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
Kelyniam Global (KLYG) has a Buyback Yield % of 0.00 as of Aug. 17, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Kelyniam Global and its competitors.
Is Kelyniam Global's Buyback Yield % too high?
Kelyniam Global's current Buyback Yield % is 0.00.
How does Kelyniam Global's Buyback Yield % compare to VASO and WCUI?
Kelyniam Global's Buyback Yield % of 0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Kelyniam Global and its competitors. Kelyniam Global's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kelyniam Global stock overvalued right now?
Kelyniam Global (KLYG) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Kelyniam Global (KLYG), the current Buyback Yield % is 0.00 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kelyniam Global Business Description

Address 97 River Road, Suite A, Canton, CT, USA, 06019
Kelyniam Global Inc specializes in the rapid production of custom prosthetic cranial implants utilizing computer-aided design and computer aided manufacturing of developed medical grade polymers. The Company develops, manufactures, and distributes custom cranial and maxilla-facial implants for patients requiring the reconstruction of cranial and certain facial structures. The Company's business operations consist of regulatory approvals, manufacturing operations and distribution to customers and markets in the United States.